Publications by authors named "Bridget Chappell"

Claim this Profile
A
ARTnet Perspectives and Contributions to Theranostics.
Roslyn J Francis, Dale L Bailey, Kathy Willowson, Melissa J Latter, Bridget Chappell

World J Nucl Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.
Marika Ciprotti, Niall C Tebbutt, Fook-Thean Lee, Sze-Ting Lee, Hui K Gan, Bridget Chappell

J Clin Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted chemoradiation in metastatic colorectal cancer: a phase I trial of 131I-huA33 with concurrent capecitabine.
Rebecca A Herbertson, Niall C Tebbutt, Fook-Thean Lee, Sanjeev Gill, Bridget Chappell

J Nucl Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers.
Rebecca A Herbertson, Niall C Tebbutt, Fook-Thean Lee, David J MacFarlane, Bridget Chappell

Clin Cancer Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.
Ian D Davis, Zhanqi Liu, Wayne Saunders, Fook-Thean Lee, Violeta Spirkoska, Bridget Chappell

Cancer Immun· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.
Andrew M Scott, Niall Tebbutt, Fook-Thean Lee, Tina Cavicchiolo, Zhanqi Liu, Bridget Chappell

Clin Cancer Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.
Andrew M Scott, Fook-Thean Lee, Niall Tebbutt, Rebecca Herbertson, Sanjeev S Gill, Bridget Chappell

Proc Natl Acad Sci U S A· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma.
Geoffrey Chong, Fook Thean Lee, Wendie Hopkins, Niall Tebbutt, Jonathan S Cebon, Bridget Chappell

Clin Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis